5-yr DMFS outcomes on the pre-operative use of MammaPrint and BluePrint for neoadjuvant decisions in the NBREaST II trial. (April 2021) - Göker, E.; Hendriks, M.P.; van Tilburg, M.; Barcaru, A.; Mittempergher, L.; van Egmond, A.; Kleijn, M.; Generali, D.